Patent · US Active

Benzimidazole and imidazopyridine derivatives and use thereof as a medicament

US8227485B2 · kind B2 · utility

1Cited by

9References

17Claims

0Family size

Assignee

IPSEN PHARMA S.A.S. · FR

Inventors

Lydie Poitout · Antony, FR
Valerie Brault · Saint-Arnoult-en-Yvelines, FR
Carole Sackur · Paris, FR
Pierre Roubert · Paris, FR
Pascale Plas · Châtillon, FR

Key dates

Filing date	May 26, 2006
Grant date	Jul 24, 2012
Priority date	—
Expiry date	Feb 24, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel benzimidazole and imidazopyridine derivatives having general formula (I), which have a good affinity with certain sub-types of melanocortin receptors, particularly MC4 receptors. Said derivatives are particularly suitable for the treatment of pathological states and diseases involving one or more melanocortin receptors. The invention also relates to pharmaceutical compositions containing said products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.